If you have been reading about cyclic peptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-03-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published research on the compound remains limited. Much of the human data comes from small, early-stage studies rather than large controlled trials, and several questions about effects and variability between individuals remain open. Investigators have examined receptor activity, pigment pathways, and related physiological responses in laboratory and animal models. Findings from those models do not automatically translate to human outcomes. Reviews frequently note the scarcity of rigorous clinical evidence and call for better-characterized study material.
Because the substance circulates mainly through informal markets, verification is a recurring theme in technical discussion. Independent analyses have found that labeled content and actual content can diverge, and that purity varies between samples. Analytical laboratories use reversed-phase chromatography to separate components and mass spectrometry to confirm identity. Isotope-labeled internal standards improve quantification in complex matrices. Such methods describe what a sample contains but say nothing about its sterility, lawful status, or suitability for any use. Open questions remain about how consistently testing is applied across the supply chain.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | No marketing authorization in major jurisdictions |
| Scheduling example | Prescription-only supply in some countries | Handled as an unlicensed medicine where restricted |
| Sports classification | Prohibited peptide | Appears on anti-doping prohibited lists |
| Reported presentation | Lyophilized vial | Nominal content varies between vendors |
| Detection approach | Liquid chromatography–tandem mass spectrometry | Used in anti-doping and forensic testing |
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
==== Sucrose treatment ==== Identical to PEG treatment process but sucrose is used instead of PEG solution. The water inside the cell walls of the wood is replaced by sucrose, rather than PEG. Originally recommended as a low-cost method for treating waterlogged wood, sucrose treatments are inconsistent in how much shrinkage they prevent, especially for severely degraded wood.
Women's suffrage was introduced in Denmark and Iceland. Gorlice–Tarnów Offensive — German forces recaptured the Austro-Hungarian fortress Przemyśl from the Russians on the Eastern Front after a three-week siege. Third Battle of Krithia — Ottoman forces counter-attacked after the Allies failed to capture Achi Baba on the Gallipoli peninsula and drive them back to the sea. The attack nearly broke British defenses, but British officer Lieutenant George Moor managed to rally retreating troops and order them to retake a critical lost trench. The action motivated the rest of the force to stand their ground, subsequently Moore was awarded the Victoria Cross for his actions. German submarine SM U-14 was shelled and sunk in the North Sea by Royal Navy ship HMT Oceanic II with the loss of one of her 28 crew. French destroyer Fantassin was accidentally rammed and damaged in the Ionian Sea by Mameluck. She was consequently scuttled by Fauconneau. British submarine HMS E11 slipped past the Dardanelles again and returned to Allied water, after a successful mission that infiltrated Istanbul and the sinking of 11 ships over a three-week period. Submarine commander Martin Dunbar-Nasmith was awarded a Victoria Cross for the mission. The prototype of the Sigrist Bus airplane by the Sopwith Aviation Company was given a test flight and achieved a new altitude record. The model was then used to develop the 1½ Strutter biplane which became available by mid-December.
spliceosome A large ribonucleoprotein complex found primarily in the nucleus of eukaryotic cells, composed of multiple small nuclear ribonucleoproteins (snRNPs) which are themselves composed of small nuclear RNAs (snRNAs) and a variety of snRNP-specific proteins. Spliceosomes assemble at the junctions between exons and introns within primary RNA transcripts and catalyze the removal of the introns and the ligation of the flanking exons in a form of post-transcriptional processing known as RNA splicing.
Carbon nanobuds are a newly created material combining two previously discovered allotropes of carbon: carbon nanotubes and fullerenes. In this new material, fullerene-like "buds" are covalently bonded to the outer sidewalls of the underlying carbon nanotube. This hybrid material has useful properties of both fullerenes and carbon nanotubes. In particular, they have been found to be exceptionally good field emitters. In composite materials, the attached fullerene molecules may function as molecular anchors preventing slipping of the nanotubes, thus improving the composite's mechanical properties. A carbon peapod is a novel hybrid carbon material which traps fullerene inside a carbon nanotube. It can possess interesting magnetic properties with heating and irradiation. It can also be applied as an oscillator during theoretical investigations and predictions. In theory, a nanotorus is a carbon nanotube bent into a torus (doughnut shape). Nanotori are predicted to have many unique properties, such as magnetic moments 1000 times larger than that previously expected for certain specific radii. Properties such as magnetic moment, thermal stability, etc. vary widely depending on the radius of the torus and the radius of the tube. Graphenated carbon nanotubes are a relatively new hybrid that combines graphitic foliates grown along the sidewalls of multiwalled or bamboo-style CNTs. The foliate density can vary as a function of deposition conditions (e.g., temperature and time) with their structure ranging from a few layers of graphene (< 10) to thicker, more graphite-like.
They invented a stochastic corrector model that assumed that replicative templates compete within compartments, and selective values of these compartments depend on the internal composition of templates. Numerical simulations showed that when stochastic effects are taken into account, compartmentalization is sufficient to integrate information dispersed in competitive replicators without the need for hypercycle organization. Moreover, it was shown that compartmentalized hypercycles are more sensitive to the input of deleterious mutations than a simple package of competing genes. Nevertheless, package models do not solve the error threshold problem that originally motivated the hypercycle.
Sources: en.wikipedia.org
On 2 March, Hospital Moinhos de Vento, the largest of the hospitals within private networks in Rio Grande do Sul, had to rent a container in order to store the bodies of dead patients at the hospital, since the morgue in the hospital had also reached capacity. The collapse of the health system continued with daily records of hospitalizations in the city. In the Hospital de Clínicas, there were not enough specialized respirators. Along with this, health professionals had to choose which patients they should intubate, due to a lack of beds. Some patients went to be intubated at hospitals and would die there. At Hospital da Restinga, patients in the overcrowded emergency ward received care sitting in chairs due to the lack of stretchers. In some hospitals, some patients died in the hospital corridors due to a lack of beds. On 5 March, the state government also announced a fine of up to 4,000 real for those who did not wear masks, in an attempt to contain the spread of COVID-19. Melo, however, declared that the city would not apply the standard, saying he would not have people abide by the decision and that the usage of prevention methods would depend on the "conscience" of people. The municipality sought to disperse encampments at different points in the city, primarily in the Cidade Baixa neighborhood, considered a hotbed for petty crime and drug use. On the 10th and 14 March, two anti-government protests called for the reopening of local businesses and military intervention, respectively. They were held despite guidance against large gatherings.
=== Disadvantage === As some proteins require chaperonin for proper folding, Komagataella is unable to produce a number of proteins, since it does not contain the appropriate chaperones. The technologies of introducing genes of mammalian chaperonins into the yeast genome and overexpressing existing chaperonins still require improvement.
It happens rarely, but it is possible for a pancreatitis attack to activate the endocrine portion of the organ back into being capable of producing insulin once again in dogs. It is possible for acute pancreatitis to cause a temporary, or transient diabetes, most likely due to damage to the endocrine portion's beta cells. Insulin resistance that can follow a pancreatitis attack may last for some time thereafter. Pancreatitis can damage the endocrine pancreas to the point where the diabetes is permanent.
Geranylgeraniol 18-hydroxylase is a cytochrome P450 protein containing heme, isolated from Croton sublyratus. It requires a partner cytochrome P450 reductase for functional expression. This uses nicotinamide adenine dinucleotide phosphate.
These included statements that God emits a cosmic broadcast of electromagnetic waves that living creatures can receive when their neural networks are enabled by DMT; that adding DMT allows people to see otherwise invisible spirits and guardian angels; that schizophrenia and autism result from an over-abundance of bioavailable DMT and should be unified under the term “Autiphrenia,” with those affected described as geniuses created to lead humanity; that vaporizing DMT had cured his brain cancer; that staring at the sun promotes DMT production in the pineal gland; and that DMT could cure other diseases. He invited cancer patients to his ranch in the Lake View Terrace area of Los Angeles to try the substance. In a video recorded after the cancer claim was questioned, Cantelmo stated that he had never had any form of cancer and that the reference was metaphorical, describing atheism as the “worst form of cancer.” His brother Craig and other family members confirmed he had never been diagnosed with cancer.
Sources: en.wikipedia.org
Only a small number of early-stage human studies have been reported, and most were limited in size and duration. No large late-stage program has established a general efficacy or safety profile. The evidence base is therefore thin compared with approved medicines.
The peptide is listed as prohibited in competitive sport, so laboratories develop detection methods and monitor for its presence. Its appearance in enforcement reports reflects that classification rather than any approved athletic use. Analytical work in this area focuses on identifying the molecule and its breakdown products in biological samples.
Chromatographic separation combined with mass spectrometry identifies the peptide and estimates its amount in a sample. Testing can confirm whether the expected molecule is present and at what concentration. It cannot establish how a product was manufactured or whether it meets any purity standard.
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.